Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WeRide Inc. Earnings Release 2000

Nov 24, 2000

49472_rns_2000-11-24_ceab3ed9-5355-4845-a191-13c885e9db0c.htm

Earnings Release

Open in viewer

Opens in your device viewer

Listed Company Information

FE PHARMA TECH<0399> - Results Announcement

Far East Pharmaceutical Technology Company Limited announced on
24/11/2000:
(stock code: 399)
Year end date: 30/6/2000 (Pro Forma
Currency: HK$ (Pro Forma Combined)
Combined) (Audited)
(Audited) Last
Current Corresponding
Period Period
from 1/7/1999 from 1/7/1998
to 30/6/2000 to 30/6/1999
('000) ('000)
Turnover : 353,116 204,027
Profit/(Loss) from Operations : 93,117 51,770
Finance cost : (148) (337)
Share of Profit/(Loss) of Associates : N/A N/A
Share of Profit/(Loss) of
Jointly Controlled Entities : N/A N/A
Profit/(Loss) after Tax & MI : 81,661 47,433
% Change over Last Period : +72%
EPS/(LPS)-Basic : 34.0 cents 19.8 cents
-Diluted : N/A N/A
Extraordinary (ETD) Gain/(Loss) : N/A N/A
Profit/(Loss) after ETD Items : 81,661 47,433
Final Dividend per Share : Nil N/A
(Specify if with other options) : N/A N/A
B/C Dates for Final Dividend : N/A
Payable Date : N/A
B/C Dates for Annual General Meeting : 20/12/2000 to 27/12/2000 bdi.
Other Distribution for Current Period : N/A
B/C Dates for Other Distribution : N/A

Remarks:

1. The Company
The Company was incorporated in the Cayman Islands as an exempted company
with limited liability on 24 May 2000 under the Companies Law (Revised) of
the Cayman Islands. On incorporation, the Company had an authorised share
capital of HK$100,000 divided into 1,000,000 shares of HK$0.10 each, one
share of which was allotted, issued and fully paid on the same day. Apart
from the foregoing, no other transactions were carried out by the Company
during the period from 24 May 2000 (date of incorporation) to 30 June
2000. Accordingly, the Company has not recorded any profits or losses for
the period.

2. Group Reorganisation
Pursuant to a reorganisation scheme (the "Group Reorganisation") to
rationalise the structure of the Group in preparation for the listing of
its shares on The Stock Exchange of Hong Kong Limited (the "Stock
Exchange") on 23 August 2000, the Company became the holding company of
the companies now comprising the Group on 26 July 2000. This was
accomplished by acquiring the entire issued share capital of Far East
Global Group Limited, which is, at the date of this report, the
intermediate holding company of the other subsidiaries, in consideration
of and in exchange for the allotment and issue of 999,999 shares of
HK$0.10 each in the share capital of the Company credited as fully paid.

3. Basis of presentation
The Group Reorganisation involved companies under common control. Because
the Group Reorganisation took place on 26 July 2000, according to the
Statement of Standard Accounting Practice No. 2.127, "Accounting for Group
Reconstructions", the Company together with its subsidiaries should only
be regarded and accounted for as a continuing group in the preparation of
the Group's financial statements commencing the year ending 30 June 2001.
Nevertheless, for the benefit of shareholders, pro forma combined
financial statements for the current year and the related notes thereto
have also been presented on the basis that the Company is treated as the
holding company of its subsidiaries for the financial years presented
rather than from the subsequent date of acquisition of the subsidiaries on
26 July 2000. The pro forma combined results of the Group for the years
ended 30 June 1999 and 2000 include the results of the Company and its
subsidiaries with effect from 1 July 1998 or since their respective dates
of incorporation, where this is a shorter period.

All significant transactions and balances among the companies comprising
the Group have been eliminated on combination.

Although the Group Reorganisation had not been completed and, accordingly,
the Group did not legally exist until July 2000, in the opinion of the
directors, the presentation of such pro forma combined financial
statements prepared on the aforesaid basis is necessary to apprise the
Company's shareholders of the Group's profit and its state of affairs as a
whole.

4. Earnings per share
The calculation of pro forma basic earnings per share is based on the pro
forma combined net profit from ordinary activities attributable to
shareholders for the year of HK$81,661,000 (1999: HK$47,433,000) and the
pro forma weighted average of 240,000,000 shares (1999: 240,000,000
shares) deemed to be in issue throughout the year.

There were no potential dilutive ordinary shares in existence for the two
years ended 30 June 2000 and accordingly, no pro forma diluted earnings
per share has been presented.